Evidence map›Paper›PMID 23582421›Full record

ArticleComparative medicine2013

A novel rat model of hereditary hemochromatosis due to a mutation in transferrin receptor 2.

Thomas B Bartnikas, Sheryl J Wildt, Amy E Wineinger, Klaus Schmitz-Abe, Kyriacos Markianos, Dale M Cooper, Mark D Fleming

Abstract read
In one paragraph

Article in Comparative medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. New Mutations inGenes · 2021
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Pathophysiology of the Belgrade rat.Frontiers in pharmacology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Thomas B BartnikasDepartment of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, USA. thomas_bartnikas@brown.edu.
Sheryl J Wildt
Amy E Wineinger
Klaus Schmitz-Abe
Kyriacos Markianos
Dale M Cooper
Mark D Fleming
Brown University · US

Funding

Metalloreductases in MedicineR01DK080011 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI FLEMING, MARK D · 2007 to 2010
$1.3M
Regulation of mammalian iron homeostasis by iron and transferrinR00DK084122 · NIDDK · BROWN UNIVERSITY · PI BARTNIKAS, THOMAS BENEDICT · 2013 to 2015
$722k
Regulation of mammalian iron homeostasis by iron and transferrinK99DK084122 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI BARTNIKAS, THOMAS BENEDICT · 2009 to 2010
$265k
NIDDK NIH HHS K99 DK084122NIDDK NIH HHS K99DK084122NIDDK NIH HHS R00 DK084122NIDDK NIH HHS R01 DK080011NIDDK NIH HHS R01DK080011
6 · The paper itself

Abstract

Sporadic iron overload in rats has been reported, but whether it is due to genetic or environmental causes is unknown. In the current study, phenotypic analysis of Hsd:HHCL Wistar rats revealed a low incidence of histologically detected liver iron overload. Here we characterized the pathophysiology of the iron overload and showed that the phenotype is heritable and due to a mutation in a single gene. We identified a single male rat among the 132 screened animals that exhibited predominantly periportal, hepatocellular iron accumulation. This rat expressed low RNA levels of the iron regulatory hormone hepcidin and low protein levels of transferrin receptor 2 (Tfr2), a membrane protein essential for hepcidin expression in humans and mice and mutated in forms of hereditary hemochromatosis. Sequencing of Tfr2 in the iron-overloaded rat revealed a novel Ala679Gly polymorphism in a highly conserved residue. Quantitative trait locus mapping indicated that this polymorphism correlated strongly with serum iron and transferrin saturations in male rats. Expression of the Gly679 variant in tissue culture cell lines revealed decreased steady-state levels of Tfr2. Characterization of iron metabolism in the progeny of polymorphic rats suggested that homozygosity for the Ala679Gly allele leads to a hemochromatosis phenotype. However, we currently cannot exclude the possibility that a polymorphism or mutation in the noncoding region of Tfr2 contributes to the iron-overload phenotype. Hsd:HHCL rats are the first genetic rat model of hereditary hemochromatosis and may prove useful for understanding the molecular mechanisms underlying the regulation of iron metabolism.

Indexed as

Disease Models, AnimalAmino Acid SequenceAnimalsAntimicrobial Cationic PeptidesChromosome MappingFemaleHemochromatosisHepcidinsIronLiverMaleMolecular Sequence DataPhenotypePolymorphism, GeneticQuantitative Trait LociRatsAntimicrobial Cationic PeptidesHAMP protein, humanHamp protein, mouseHamp protein, ratHepcidinsIronReceptors, TransferrinRNATfr2 protein, rat

Identifiers

PMID23582421
PMCPMC3625055
OpenAlexW1605406005

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.